Approaching Airway Inflammation From Another Angle: The Rationale for Targeting Type 2 Pathways in COPD

•Download as PPT, PDF•

0 likes•13 views

Claus Vogelmeier, MD, and Nicola Hanania, MD, MS, discuss chronic obstructive pulmonary disease in this CE activity titled "Approaching Airway Inflammation From Another Angle: The Rationale for Targeting Type 2 Pathways in COPD." For the full presentation, please visit us at www.peervoice.com/JHP870.

Health & Medicine

Approaching Airway Inflammation From Another Angle: The Rationale for Targeting Type 2 Pathways in COPD

Recently uploaded

Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central

19various

Ketone bodies and metabolism-biochemistry

Dhayanithi C

Post-Menstrual Smell- When to Suspect Vaginitis.pptx

FFragrant

Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx

Dr. Rabia Inam Gandapore

Cardiac Assessment for B.sc Nursing Student.pdf

shivalingatalekar1

Tests for analysis of different pharmaceutical.pptx

taiba qazi

Adhd Medication Shortage Uk - trinexpharmacy.com

reignlana06

The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com

Efficacy of Avartana Sneha in Ayurveda

Dr. Jyothirmai Paindla

Histololgy of Female Reproductive System.pptx

AyeshaZaid1

Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.

Cervical Disc Arthroplasty ORSI 2024.pptx

LEFLOT Jean-Louis

Does Over-Masturbation Contribute to Chronic Prostatitis.pptx

walterHu5

Cell Therapy Expansion and Challenges in Autoimmune Disease

Health Advances

There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities. In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions. Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved. Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.

Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx

Dr. Rabia Inam Gandapore

June 2024 Oncology Cartoons By Dr Kanhu Charan Patro

Kanhu Charan

Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...

Kosmoderma Academy Of Aesthetic Medicine

K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu

HongBiThi1

Complementary feeding in infant IAP PROTOCOLS

chiranthgowda16

pathology MCQS introduction to pathology general pathology

ZayedKhan38

NARCOTICS- POLICY AND PROCEDURES FOR ITS USE

Dr. Ahana Haroon

Pharmacology of 5-hydroxytryptamine and Antagonist

Dr. Nikhilkumar Sakle

5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness. It is mostly found in the brain, intestines, and blood platelets. 5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin. It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.

Recently uploaded (20)